Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 17 studies | 44% ± 15% | |
peripheral blood | 16 studies | 46% ± 18% | |
intestine | 10 studies | 44% ± 22% | |
kidney | 7 studies | 41% ± 18% | |
liver | 6 studies | 28% ± 14% | |
uterus | 5 studies | 65% ± 19% | |
lymph node | 5 studies | 43% ± 21% | |
placenta | 4 studies | 31% ± 11% | |
bone marrow | 4 studies | 32% ± 11% | |
prostate | 4 studies | 57% ± 13% | |
skin | 4 studies | 59% ± 8% | |
breast | 4 studies | 62% ± 9% | |
pancreas | 3 studies | 28% ± 6% | |
eye | 3 studies | 39% ± 25% | |
adrenal gland | 3 studies | 43% ± 18% | |
esophagus | 3 studies | 45% ± 13% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
skin | 100% | 14536.89 | 1809 / 1809 | 100% | 127.60 | 472 / 472 |
uterus | 100% | 10490.60 | 170 / 170 | 100% | 130.74 | 457 / 459 |
bladder | 100% | 12253.81 | 21 / 21 | 99% | 126.69 | 500 / 504 |
lung | 100% | 23654.69 | 577 / 578 | 99% | 94.69 | 1145 / 1155 |
esophagus | 98% | 7778.39 | 1417 / 1445 | 100% | 113.70 | 183 / 183 |
intestine | 97% | 7425.55 | 941 / 966 | 100% | 96.87 | 525 / 527 |
breast | 99% | 10990.40 | 455 / 459 | 97% | 65.14 | 1089 / 1118 |
prostate | 97% | 6628.06 | 237 / 245 | 99% | 108.62 | 499 / 502 |
kidney | 97% | 8973.53 | 86 / 89 | 99% | 102.88 | 896 / 901 |
ovary | 100% | 9877.05 | 180 / 180 | 96% | 47.21 | 412 / 430 |
thymus | 96% | 7898.67 | 624 / 653 | 99% | 99.84 | 599 / 605 |
adrenal gland | 95% | 6660.82 | 245 / 258 | 99% | 94.39 | 227 / 230 |
stomach | 86% | 7215.21 | 307 / 359 | 99% | 82.39 | 284 / 286 |
brain | 59% | 3566.58 | 1568 / 2642 | 91% | 45.99 | 645 / 705 |
liver | 65% | 4054.61 | 146 / 226 | 79% | 42.21 | 322 / 406 |
pancreas | 23% | 945.09 | 74 / 328 | 99% | 136.90 | 177 / 178 |
eye | 0% | 0 | 0 / 0 | 100% | 78.24 | 80 / 80 |
spleen | 100% | 7276.85 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 114.45 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 91.11 | 1 / 1 |
adipose | 100% | 16216.14 | 1202 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 13402.38 | 1331 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 99% | 18926.15 | 923 / 929 | 0% | 0 | 0 / 0 |
heart | 98% | 11424.46 | 840 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 97% | 60.53 | 28 / 29 |
muscle | 93% | 5550.95 | 746 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0070059 | Biological process | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress |
GO_0034976 | Biological process | response to endoplasmic reticulum stress |
GO_0032515 | Biological process | negative regulation of phosphoprotein phosphatase activity |
GO_1902310 | Biological process | positive regulation of peptidyl-serine dephosphorylation |
GO_0006974 | Biological process | DNA damage response |
GO_0070972 | Biological process | protein localization to endoplasmic reticulum |
GO_0036496 | Biological process | regulation of translational initiation by eIF2 alpha dephosphorylation |
GO_1903898 | Biological process | negative regulation of PERK-mediated unfolded protein response |
GO_0006915 | Biological process | apoptotic process |
GO_0032516 | Biological process | positive regulation of phosphoprotein phosphatase activity |
GO_1903917 | Biological process | positive regulation of endoplasmic reticulum stress-induced eIF2 alpha dephosphorylation |
GO_0032058 | Biological process | positive regulation of translational initiation in response to stress |
GO_0035308 | Biological process | negative regulation of protein dephosphorylation |
GO_0051726 | Biological process | regulation of cell cycle |
GO_0000164 | Cellular component | protein phosphatase type 1 complex |
GO_0016020 | Cellular component | membrane |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0005739 | Cellular component | mitochondrion |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0005741 | Cellular component | mitochondrial outer membrane |
GO_0019901 | Molecular function | protein kinase binding |
GO_0008157 | Molecular function | protein phosphatase 1 binding |
GO_0072542 | Molecular function | protein phosphatase activator activity |
GO_0019888 | Molecular function | protein phosphatase regulator activity |
GO_0005515 | Molecular function | protein binding |
Gene name | PPP1R15A |
Protein name | Protein phosphatase 1 regulatory subunit 15A (Growth arrest and DNA damage-inducible protein GADD34) Protein phosphatase 1 regulatory subunit 15A Protein phosphatase 1 regulatory subunit 15A (Growth arrest and DNA damage-inducible protein GADD34) (Myeloid differentiation primary response protein MyD116 homolog) |
Synonyms | GADD34 |
Description | FUNCTION: Recruits the serine/threonine-protein phosphatase PPP1CA to prevents excessive phosphorylation of the translation initiation factor eIF-2A/EIF2S1, thereby reversing the shut-off of protein synthesis initiated by stress-inducible kinases and facilitating recovery of cells from stress . Down-regulates the TGF-beta signaling pathway by promoting dephosphorylation of TGFB1 by PP1 . May promote apoptosis by inducing p53/TP53 phosphorylation on 'Ser-15' . Plays an essential role in autophagy by tuning translation during starvation, thus enabling lysosomal biogenesis and a sustained autophagic flux . Acts also a viral restriction factor by attenuating HIV-1 replication . Mechanistically, mediates the inhibition of HIV-1 TAR RNA-mediated translation . .; FUNCTION: (Microbial infection) Promotes enterovirus 71 replication by mediating the internal ribosome entry site (IRES) activity of viral 5'-UTR. . |
Accessions | ENST00000704026.1 A0A994J4D6 A0A994J786 ENST00000200453.6 [O75807-1] ENST00000704027.1 ENST00000600406.2 O75807 M0QXL1 |